Both BPC-157 and TB-500 are sold for research purposes only and are not intended for human use.
This guide compares the two compounds directly — their origins, mechanisms, research areas, and practical handling considerations.
Origins and Background
BPC-157
BPC-157 (Body Protection Compound 157) is a 15-amino-acid synthetic peptide derived from a protein found in human gastric juice. It was first isolated in the 1990s by researchers studying the cytoprotective properties of the gastric mucosa. Its stability in acidic environments and broad range of preclinical effects have made it a widely used research tool.
Read the full overview: What is BPC-157?
TB-500
TB-500 is a synthetic fragment of Thymosin Beta-4 (Tβ4), a naturally occurring protein found in virtually all human and animal cells. Tβ4 plays a fundamental role in actin polymerisation — the process by which cells build their internal structural skeleton and move through tissue. TB-500 corresponds to the actin-binding domain of Thymosin Beta-4 (specifically the amino acid sequence LKKTETQ) and is studied because it appears to retain many of the biological activities of the full-length protein in preclinical models.
Mechanisms of Action: Where They Differ
| Property | BPC-157 | TB-500 |
|---|---|---|
| Origin | Derived from gastric protein BPC | Fragment of Thymosin Beta-4 (Tβ4) |
| Length | 15 amino acids | 7 amino acids (LKKTETQ) |
| Primary Mechanism | Angiogenesis, growth factor modulation, NO pathway, FAK/Src signalling | Actin sequestration, cell migration, anti-inflammatory |
| Vascular Effects | Strong — stimulates VEGF/angiogenesis | Moderate — supports vessel formation indirectly |
| Cell Migration | Moderate | Strong — primary mechanism |
| Key Tissue Focus | Gut, tendon, bone, systemic | Muscle, skin, heart, eye, systemic |
| Stability | High — stable in acidic environments | Moderate — standard peptide stability |
| Research Volume | Very high — extensive preclinical data | High — strong research base |
Research Areas: Where Each Compound Has Been Studied
BPC-157 Preclinical Research Focus
- Tendon and ligament repair: multiple rodent models showing accelerated healing and improved tissue organisation
- Gastrointestinal integrity: protective effects in ulcer, anastomosis, and inflammatory bowel models
- Bone and joint repair: studied in fracture healing and arthritic models
- Neurological models: brain injury and spinal cord damage recovery
- Systemic cytoprotection: broad protective effects across multiple organ systems
TB-500 Preclinical Research Focus
- Muscle injury recovery: crush injury and ischaemia-reperfusion models showing improved fibre regeneration
- Cardiac repair: myocardial infarction models showing improved ejection fraction and reduced infarct size
- Skin wound healing: accelerated wound closure and reduced scarring in wound models
- Ocular repair: corneal wound healing models
- Anti-inflammatory effects: reduction in inflammatory cytokine markers across multiple models
Which to Choose for Your Research?
The right compound depends on the biological question you're investigating:
- For gastrointestinal, vascular, or tendon/ligament-focused research: BPC-157 is the more established tool with a larger preclinical evidence base in these areas.
- For muscle fibre repair, cardiac tissue, skin healing, or research specifically focused on actin dynamics and cell migration: TB-500 is the more targeted choice.
- For research exploring combined recovery pathways or studying potential synergistic effects of complementary mechanisms: the BPC-157 + TB-500 blend provides both compounds in a single preparation.
Browse products: BPC-157 | TB-500 | BPC-157 + TB-500 Blend
Research Use Disclaimer: All peptides sold by Apex Sequence are intended strictly for in vitro research and laboratory use only. They are not intended for human or veterinary use, consumption, or therapeutic application of any kind. These products have not been evaluated by Health Canada or the FDA for safety or efficacy in humans. By purchasing, you confirm you are a qualified researcher using products in accordance with all applicable laws.
Reviewed by the Apex Sequence editorial team • Last updated: March 2026 • Sources: PubMed / NCBI